OTCMKTS:IBXNF IBEX Technologies (IBXNF) Stock Price, News & Analysis → Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (From Banyan Hill Publishing) (Ad) Free IBXNF Stock Alerts $1.00 0.00 (0.00%) (As of 04/11/2024) Add Compare Share Share Today's Range$1.00▼$1.0050-Day Range$1.00▼$1.0752-Week Range$0.56▼$1.10VolumeN/AAverage Volume12,070 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsHeadlinesShort InterestStock AnalysisChartFinancialsHeadlinesShort Interest Get IBEX Technologies alerts: Email Address Ad Awesomely, LLCAutomatic Income (from home)For over 22 years, Wall Street elites have kept this little-known "income hack" from everyday investors… 6 simple clicks have set up HUGE payouts for "in-the-know" investors… Delivering them passive income 365 days a year. Just click here now to watch my presentation for free. About IBEX TechnologiesIBEX Technologies Inc., through its subsidiaries, manufactures and markets enzymes for biomedical use in Canada, the United States, Germany, the United Kingdom, and internationally. It offers a portfolio of recombinant glycosaminoglycan lyases, including Heparinase I, Heparinase II, Heparinase III, Chondroitinase AC, and Chondroitinase B; collagen ELISAs for the study of synthesis and degradation of connective tissue components; collagen antibodies; and diamine oxidase liquid. The company also manufactures and markets a range of arthritis assays, which are used in osteoarthritis research. In addition, it provides lyophilization services for making disposable medical device components; and custom fermentation and contract manufacturing services. It serves manufacturers of medical devices, quality control labs, low molecular weight heparin manufacturers, and academic research institutions. IBEX Technologies Inc. was incorporated in 1972 and is based in Montreal, Canada.Read More IBXNF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IBXNF Stock News HeadlinesApril 5, 2024 | seekingalpha.comIBT:CA IBEX Technologies Inc.March 22, 2024 | finance.yahoo.comIBEX Reports Results for the Second Quarter and Six Months Ended January 31, 2024May 4, 2024 | Stansberry Research (Ad)Global crypto currency reset (41 major banks signed up)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project...February 12, 2024 | finance.yahoo.comIBEX Technologies Signs Definitive Agreement for Sale of the Company for $1.45 Cash Per ShareFebruary 9, 2024 | msn.comWhy IBEX Limited Stock Fell TodayJanuary 23, 2024 | reuters.comIBEX 35 IndexDecember 18, 2023 | finance.yahoo.comIBEX Technologies First Quarter 2024 Earnings: EPS: CA$0.03 (vs CA$0.03 in 1Q 2023)December 14, 2023 | finance.yahoo.comIBEX Reports Results for the First Quarter Ended October 31, 2023May 4, 2024 | Stansberry Research (Ad)Global crypto currency reset (41 major banks signed up)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project...November 11, 2023 | markets.businessinsider.comIBEX Outperforms Amid Economic Pressure: A Buy RecommendationNovember 9, 2023 | finance.yahoo.comIBEX Reports Results for the Year Ended July 31, 2023August 29, 2023 | finance.yahoo.comA Look At The Intrinsic Value Of IBEX Technologies Inc. (CVE:IBT)July 17, 2023 | finance.yahoo.comIBEX Technologies Announces Renewal of Normal Course Issuer BidJune 7, 2023 | finance.yahoo.comIBEX Reports Results for the Third Quarter and the Nine Months Ended April 30, 2023April 13, 2023 | wsj.comIBEX Ltd.March 20, 2023 | financialpost.comIBEX Reports Results for the Second Quarter and the Six Months Ended January 31, 2023January 19, 2023 | finance.yahoo.comShareholders Will Probably Hold Off On Increasing IBEX Technologies Inc.'s (CVE:IBT) CEO Compensation For The Time BeingJanuary 6, 2023 | finance.yahoo.comIBEX Technologies Inc.'s (CVE:IBT) Stock's On An Uptrend: Are Strong Financials Guiding The Market?December 15, 2022 | finance.yahoo.comIBEX Reports Results for the First Quarter Ended October 31, 2022November 17, 2022 | finance.yahoo.comIBEX Technologies Full Year 2022 Earnings: EPS: CA$0.067 (vs CA$0.031 in FY 2021)November 10, 2022 | finance.yahoo.comIBEX Reports Results for the Year Ended July 31, 2022September 30, 2022 | benzinga.comIBEX 35 Futures (ES35)September 14, 2022 | msn.comUS Stocks Open Higher, Producer Prices Decline for 2nd MonthJuly 30, 2022 | finance.yahoo.comAre IBEX Technologies Inc.'s (CVE:IBT) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?June 10, 2022 | finance.yahoo.comIBEX Reports Results for the Third Quarter and the Nine Months Ended April 30, 2022March 18, 2022 | seekingalpha.comIbex Technologies reports FQ2 resultsMarch 17, 2022 | finance.yahoo.comIBEX Reports Results for the Second Quarter and the Six Months Ended January 31, 2022See More Headlines Receive IBXNF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IBEX Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings12/19/2013Today5/04/2024Next Earnings (Estimated)6/05/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolOTCMKTS:IBXNF CUSIPN/A CIK890859 Webwww.ibex.ca Phone(514) 344-4004FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesMr. Paul Baehr (Age 81)President, CEO & Chairman Comp: $299.07kBelinda Franco C.A.CPA, CFO, VP of Finance & Administration and SecretaryMr. Mahendra Kumar PallapothuVice President of OperationsKey Competitors180 Life SciencesNASDAQ:ATNFW3SBioOTCMKTS:TRSBF60 Degrees PharmaceuticalsNASDAQ:SXTPWAbcamOTCMKTS:ABCZFAdociaOTCMKTS:ADOIFView All Competitors IBXNF Stock Analysis - Frequently Asked Questions How have IBXNF shares performed in 2024? IBEX Technologies' stock was trading at $0.86 at the beginning of the year. Since then, IBXNF stock has increased by 16.3% and is now trading at $1.00. View the best growth stocks for 2024 here. When is IBEX Technologies' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, June 5th 2024. View our IBXNF earnings forecast. How were IBEX Technologies' earnings last quarter? IBEX Technologies Inc. (OTCMKTS:IBXNF) announced its quarterly earnings results on Thursday, December, 19th. The company reported ($0.02) EPS for the quarter. How do I buy shares of IBEX Technologies? Shares of IBXNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:IBXNF) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchCould Your Accounts Be Frozen?Allegiance GoldThe Gold Grab of the CenturyColonial MetalsStock-Picking AI Predicts #1 Stock of 2024AltimetryThe only AI company you should be looking atBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IBEX Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.